Thyroid hormone receptors (TRs) exert tumor-suppressive effects by inhibiting the expression of PTTG1 and the transcription factor Sp1, emphasizing the critical role of the TR-Sp1-PTTG1 signaling axis in HCC progression [45]. Here, SP1 is linked to neoplasm.